Anticoagulant drug choice in patients who have had bariatric surgery - Presently, DOACs are not the preferred choice

Thromb Res. 2018 Mar:163:196-199. doi: 10.1016/j.thromres.2018.01.027. Epub 2018 Jan 31.

Authors

Stephan Moll¹, Karlyn A Martin²

Affiliations

¹ University of North Carolina School of Medicine, Department of Medicine, Division of Hematology-Oncology, Chapel Hill, NC, USA. Electronic address: smoll@med.unc.edu.
² Northwestern University, Department of Medicine, Division of Hematology-Oncology, Chicago, IL, USA.

PMID: 29395241
DOI: 10.1016/j.thromres.2018.01.027

No abstract available

Publication types

Editorial
Comment

MeSH terms

Administration, Oral
Anticoagulants*
Bariatric Surgery
Humans
Vitamin K*

Substances

Anticoagulants
Vitamin K